View all veterinary jobs
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
Vetsonic has launched Otimectin vet, an ivermectin-based topical preparation for the treatment of Otodectes cynotis infections in cats.
The new product offers a once-weekly dosing alternative to traditional ear mite treatments, which commonly require twice daily administration over 7 to 21 days.
Presented as a gel in a 10g tube complete with application spout, Otimectin vet is a 1 mg/g ivermectin preparation. It does not contain an antibiotic or steroids.
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.